Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.

ABSTRACT:

Objective

The United States Office of the National Coordinator for Health Information Technology sponsored the development of a "high-priority" list of drug-drug interactions (DDIs) to be used for clinical decision support. We assessed current adoption of this list and current alerting practice for these DDIs with regard to alert implementation (presence or absence of an alert) and display (alert appearance as interruptive or passive).

Materials and methods

We conducted evaluations of electronic health records (EHRs) at a convenience sample of health care organizations across the United States using a standardized testing protocol with simulated orders.

Results

Evaluations of 19 systems were conducted at 13 sites using 14 different EHRs. Across systems, 69% of the hig

SUBMITTER: McEvoy DS 

PROVIDER: S-EPMC5391726 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature